Centerpulse/Sulzer Cuts Settlement Opt-Outs To 87, Sidesteps Bankruptcy

Centerpulse plans to "aggressively defend" in court any outstanding claims related to its Inter-Op hip implant and Natural Knee II recalls that were not part of a class settlement, but the firm has not ruled out the possibility of settling those claims out of court

More from Archive

More from Medtech Insight